Journal of Cell Biology and Genetics
Subscribe to JCBG
Full Name*
Email Address*

Article Number - 5BD7ADB53698


Vol.5(1), pp. 1-9 , June 2015
DOI: 10.5897/JCBG2014.0036
ISSN: 2141-6516



Full Length Research Paper

Pancreatic response after treatment with 1,5-Bis(3,5- dimethylpyrazol-1-yl)-3-oxapentane diacetatocopper in rats



Nofa, A.E.*
  • Nofa, A.E.*
  • Department of Zoology, Faculty of Science, Menoufia University, Egypt.
  • Google Scholar
Lampatov, V.V.
  • Lampatov, V.V.
  • Department of Pharmacology, Altai State Medical University, Barnaul, Russia.
  • Google Scholar
Lepilov, A.V.
  • Lepilov, A.V.
  • Department of Pathological Anatomy, Altai State Medical University, Barnaul, Russia.
  • Google Scholar







 Received: 18 January 2014  Accepted: 12 June 2015  Published: 30 June 2015

Copyright © 2015 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0


3,5-Dimethylpyrazole (U-6245) is a hypoglycemic and antilipolytic agent used in the treatment of diabetes mellitus. Complex 1,5-Bis(3,5-dimethylpyrazol-1-yl)-3-oxapentane diacetatocopper was prepared in 2009. This study indicated that 1,5-Bis(3,5-dimethylpyrazol-1-yl)-3- oxapentane-diacetatocopper has hypoglycemic properties by decreasing glucose level in blood but caused histopathological changes in the pancreas rats. Rats treated with 1,5-Bis(3,5-dimethylpyrazol-1- yl)-3-oxapentane diacetatocopper for 2, 4 and 6 weeks revealed inflammatory infiltration in the pancreas, marked cytoplasmic vacuoles, congestion of blood vessels with edema and haemorrhage, as well as, some of the degenerated cells showed necrosis. Large spaces were detected in some areas due to degeneration of cells. Sera of animals treated with 1,5-Bis(3,5-dimethylpyrazol-1-yl)-3-oxapentane diacetatocopper in the present study revealed a significant decrease in serum glucose after 2, 4 and 6 weeks of treatment.

Key words: Hypoglycemic agent, glucose, pancreas, necrosis.

Bae SH, Sung SH, Lee HE, Kang HT, Lee SK, Oh SY, Woo HA, Kil IS, Rhee SG (2012). Peroxiredoxin III and sulfiredoxin together protect mice from pyrazole-induced oxidative liver injury. Antioxid. Redox. Signal. (17)10:1351-1361c.
crossref
 
Bergamini E, De Tata V, Cubeddu TL, Masiello P, Pollera M (1987). Increased degradation in rat liver induced by antilipolytic agents: A model for studying autophagy and protein degradation in Liver. Exp. Mol. Pathol. 46:114-122.
crossref
 
Bergmeyer HU, Bernt E, Schmidt F, Stork H (1974). D-Glucose determination with hexokinase and glucose-6-phosphate dehydrogenase. New York pp. 1196-1201.
 
Butler LK (1995). Regulation of blood glucose levels in normal and diabetic rats. Texas-Austin pp.181-202.
 
Choia MK, Hana JK, Kima HJ, Leea SK, Leeb JS, Wangc JH, Sond SW, Parka HJ, Son CG (2013). Aqueous extract of Artemisia capillaris exerts hepatoprotective action in alcohol–pyrazole-fed rat model. J. Ethnopharmacol. 147:662-670c
crossref
 
Donati A, Taddel M, Cavallini G, Bergamini E (2006). Stimulation of macroautophagy Can Rescue Older Cells from 8-OHdG mtDNA Accumulation: A Safe and Easy Way to Meet Goals in the SENS Agenda. Rejuvenation Res. 9(3):408-412.
crossref
 
Donati A, Ventrutia A, Cavallinia G, Masinia M, Vittorinia S, Chantretb I, Codognob P, Bergamini E (2008). In vivo effect of an antilipolytic drug (3,5-dimethylpyrazole) on autophagic proteolysis and autophagy-related gene expression in rat liver. Biochem. Biophys. Res. Commun. 366:786-792.
crossref
 
George CG, William ED (1965). Effect of a New Hypoglycemic Agent, 3,5-Dimethylpyrazole, on Carbohydrate and Free Fatty Acid Metabolism. Diabetes (14)8:507-515.
 
Kroigaard C, Misfeldt M, Bek T, Simonsen U (2010). Openers of small conductance calcium- activated potassium channels selectively enhance NO-mediated bradykinin vasodilatation in porcine retinal arteriole. Br. J. Pharmacol. 160:1496-1508c.
crossref
 
Lillie RD, Fulmer HM (1976). Histopathological Technique and Practical Histochemistry. 4th edn. New York, Mc Graw Hill.
 
Locci CT, Bergamini E (1983). Effects of antilipolytic agents on peroxisomal beta-oxidation of fatty acids in rat liver. Biochem. Pharmacol. 32(11):1807-1809.
crossref
 
Locci CT, Masiello P, Pollera M, Bergamini E (1985). Effects of antilipolytic agents on rat liver peroxisomes and peroxisomai oxidative activities. Biochim. Biophys. Acta. 839:96-104c.
crossref
 
Lu Y, Cederbaum AI (2006). Enhancement by pyrazole of lipopolysaccharide-induced liver injury in mice: role of cytochrome. Hepatology 44(1):263-274.
crossref
 
Manuel S, Clotilde M, Pilar N, Laurent L, Enrique G, Carlos M, Oscar H, Francisco O, Fernando G, Javier P, Francisco A (2012). In vitro and in Vivo Trypanosomicidal Activity of Pyrazole Containing Macrocyclic and Macrobicyclic Polyamines: Their Actionon Acute and Chronic Phases of Chagas Disease. J. Med. Chem. 55:4231-4424c.
crossref
 
Masiello P, Novelli M, Bombara M, Fierabracci V, Vittorini S, Prentki M, Bergamini E (2002). The antilipolytic agent 3,5-dimethylpyrazole inhibits insulin release in response to both nutrient secretagogues and cyclic adenosine monophosphate agonists in isolated rat islets. Metabolism 51(1):110-114.
crossref
 
Potapov AS, Domina GA, Domina GA, Khlebnikov AI, Ogorodnikov VD (2007). Facile synthesis of flexible Bis(pyrazol-1-yl) alkane and related ligands in a superbasic medium. Eur. J. Org. Chem. 30:5112-5116.
crossref
 
Potapov AS, Nudnova EA, Domina GA, Kirpotina LN, Quinn MT, Khlebnikov AI, Schepetkin IA (2009). Synthesis, characterization and potent superoxide dismutase-like activity of novel bis(pyrazole)–2,2-bipyridyl mixed ligand copper(II) complexes. Dalton Trans. 23:4488-4498.
crossref
 
Richard IG, Clive SC, Allan F, Barry JG (2010). Textbook of Diabetes, 4th Edition. Black well Publishing.
 
Ritva PE, Mandy MR, Emily H, Carolyn B (1983). Pyrazole Effects on Mutagenicity and Toxicity of Dimethylnitrosamine in Wistar Rats. Cancer Res. 43(2):496-9.
 
Wang X, Wu D, Yang L, Cederbaum AI (2011). Hepatotoxicity mediated by pyrazole (cytochrome P450 2E1) plus tumor necrosis factor alpha treatment occurs in c-Jun N-terminal kinase 2-/- but not in c-Jun N-terminal kinase 1-/- mice. Hepatology (54)5:1753-1766c.
crossref
 
Yamada M, Murawaki Y, Hirayama C (1987). Effects of ethanol feeding on collagen synthesizing and degrading enzymes in rat pancreas. Biochem. Pharmacol. (36)20:3361-3364.
crossref
 
Yongke L, Xiaodong W, Cederbaum AI (2005). Lipopolysaccharide-induced liver injury in rats treated with the CYP2E1 inducer pyrazole. Am. J. Physiol. Gastrointest. Liver Physiol. 289(2):G308-19
crossref

 


APA Nofa, A. E.*, Lampatov, V. V. & Lepilov, A. V. (2015). Pancreatic response after treatment with 1,5-Bis(3,5- dimethylpyrazol-1-yl)-3-oxapentane diacetatocopper in rats. Journal of Cell Biology and Genetics, 5(1), 1-9.
Chicago Nofa, A.E., Lampatov, V.V. and Lepilov, A.V.. "Pancreatic response after treatment with 1,5-Bis(3,5- dimethylpyrazol-1-yl)-3-oxapentane diacetatocopper in rats." Journal of Cell Biology and Genetics 5, no. 1 (2015): 1-9.
MLA Nofa, et al. "Pancreatic response after treatment with 1,5-Bis(3,5- dimethylpyrazol-1-yl)-3-oxapentane diacetatocopper in rats." Journal of Cell Biology and Genetics 5.1 (2015): 1-9.
   
DOI 10.5897/JCBG2014.0036
URL http://academicjournals.org/journal/JCBG/article-abstract/5BD7ADB53698

Subscription Form